Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

On Friday, DexCom Inc (DXCM) stock saw a modest uptick, ending the day at $75.88 which represents a slight increase of $1.20 or 1.61% from the prior close of $74.68. The stock opened at $75.51 and ...

The agency approved the first CGM for over-the-counter use in March. Stelo, by Dexcom, was approved for anyone 18 and older ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

Tiger Global Management filed its latest Form 13F, revealing over $23 billion in assets under management. The hedge fund led ...

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

On Wednesday, DexCom Inc (DXCM) stock saw a decline, ending the day at $72.53 which represents a decrease of $-1.81 or -2.43% from the prior close of $74.34. The stock opened at $74.46 and touched a ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...